@Aceman99 - good share, thanks mate. A few interesting data...

@Aceman99 - good share, thanks mate. A few interesting data points.

Cap raise only 40% over-subscribed so not a huge uptake, explains limited follow-on buying on market. I still think the ASX is the wrong home for CLB. Aussies don’t eat a lot of candy and CLB have no product in market here so it’s not an easy one for retail punters to get their heads around. And institutional interest still seems limited / almost non existent.

This was probably my favourite sound bite: “No sale and return, we haven’t given any markdown money, never taken any product back since inception, full stop, and that’s an absolute”. Nice

With the US vaccine roll out accelerating, the CDC has been relaxing guidance (see below eg) which should lead to greater foot traffic in brick and mortar stores in 2H 2021. Hopefully this translates into additional sales for CLB through these channels.
https://www.nytimes.com/2021/04/27/us/politics/coronavirus-masks-outdoors.html

gltah